Aptorum Group Limited (NASDAQ:APM) Sees Large Increase in Short Interest

Aptorum Group Limited (NASDAQ:APM) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 13,100 shares, an increase of 184.8% from the October 31st total of 4,600 shares. Approximately 0.6% of the company’s shares are sold short. Based on an average daily trading volume, of 32,600 shares, the short-interest ratio is currently 0.4 days.

Aptorum Group Stock Performance

NASDAQ APM opened at $0.71 on Thursday. Aptorum Group has a one year low of $0.46 and a one year high of $17.49. The company’s 50 day moving average price is $1.47 and its 200 day moving average price is $2.98.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.